Company Filing History:
Years Active: 2017-2024
Title: Piotr Nieczypor: Innovator in ENPP1 Inhibition
Introduction
Piotr Nieczypor is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). With a total of 3 patents, his work focuses on innovative compounds that have the potential to treat diseases mediated by ENPP1.
Latest Patents
Nieczypor's latest patents include groundbreaking research on heterocyclic inhibitors of ENPP1. This patent discusses triazolopyrimidine and imidazolopyrimidine inhibitors, detailing their compositions and methods of use for treating related diseases. Another significant patent involves imino sulfanone inhibitors of ENPP1, which highlights sulfoximine-based inhibitors and their therapeutic applications. These patents reflect his commitment to advancing medical science through innovative solutions.
Career Highlights
Throughout his career, Piotr Nieczypor has worked with prominent companies such as Volastra Therapeutics, Inc. and Laboratorios Del Dr. Esteve S.A. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medicinal chemistry.
Collaborations
Some of his notable coworkers include Derek A. Cogan and Sarah Bettigole. Their collaborative efforts have played a crucial role in the development of his innovative patents and research.
Conclusion
Piotr Nieczypor stands out as a significant figure in the realm of ENPP1 inhibition, with a focus on developing effective therapeutic agents. His patents and collaborations reflect a dedication to advancing healthcare through innovative research.